News
Menopause: UK approves daily pill for hot flushes
BMJ 2023; 383 doi: https://doi.org/10.1136/bmj.p2969 (Published 19 December 2023) Cite this as: BMJ 2023;383:p2969
- Elisabeth Mahase
- The BMJ
A new once daily, non-hormonal pill that reduces hot flushes and night sweats caused by menopause has been approved by the UK’s drugs regulator.12
Fezolinetant, marketed as Veoza, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) for moderate to severe vasomotor symptoms associated with menopause.
The drug’s manufacturer, Astellas, has said the pill …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £184 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£50 / $60/ €56 (excludes VAT)
You can download a PDF version for your personal record.